Shareholder/Investor Information | Taisho Pharmaceutical Co., Ltd.

General Stock Information

	- Accounting Period		April 1st to March 31st of following year
	- Annual Shareholders' Meeting		Held in June every year
	- Dividends Date		March 31st
	- Administrator of Shareholders' Register		Mitsubishi UFJ Trust and Banking Corporation 1-4-5 Marunouchi, Chiyoda-ku, Tokyo, Japan
	- Contact Address/Shipping Address		Corporate Agency Division Mitsubishi UFJ Trust and Banking Corporation 7-10-11 Higashisuna, Koto-ku, Tokyo 137-8081, Japan Tel: 0120-232-711 (toll-free in Japan)

- Securities Code

4535

- Listed Stock Exchanges

Tokyo Stock Exchange

- Stock Trading Unit

1,000 shares

- Number of Authorized Shares

Common Stock 1,174,959,000 shares

- Number of Shares Outstanding

Common Stock 300,465,510 shares

- Number of Shareholders

37,282

- Major Shareholders (Top 10 List)

Rank	Shareholder	Number of Shares Owned(1,000s)*	Percentage of Voting Rights(%)**
1	The Uehara Memorial Foundation	43,000	15.08
2	Shoji Uehara	36,614	12.84
3	Taisho Pharmaceutical Co., Ltd.	15,365	-
4	Sumitomo Mitsui Banking Corporation	10,000	3.51
4	The Bank of Tokyo-Mitsubishi UFJ, Ltd.	10,000	3.51
4	Uehara Museum of Modern Art Foundation	10,000	3.51
7	Japan Trustee Services Bank, Ltd. (trust account)	8,411	2.95
8	Akira Uehara	7,145	2.51
9	Sumitomo Chemical Co., Ltd.	7,033	2.47
10	The Master Trust Bank of Japan, Ltd. (trust account)	5,602	1.96

* Number of shares is rounded down to the nearest 1,000.

** Calculated excluding treasury stocks (15,365 thousand shares)

- Dividend Recording Date

Year-end March 31st
Interim September 30th
*Taisho introduced the interim dividend system in FY2007.

- Change in Dividends per Share

- Dividend Payment Term

Dividend payment is three years after the start date. (Please note that this policy is founded on the Company's Articles of Incorporation.)